Malignant Peritoneal Neoplasm — Trials

Malignant Peritoneal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

502 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 124
Recruiting: 53
Ph III recruiting: 7
Growth YoY: —
Industry share: 18%
Top sponsor: National Cancer Institute (NCI)
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (75)

clinicaltrialsPublishedShowing 1–12 of 12 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06161272	Fluzoparib With or Without Apatinib in Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With PARPi	unknown	Phase 2	80	Guangxi Medical UniversityOTHER	1	Dec 7, 2023	clinicaltrials
NCT03363867	BEACON - ABC in Recurrent Platinum Resistant HGSOC(BEACON)	unknown	Phase 2	30	Peter MacCallum Cancer Centre, AustraliaOTHER	1	Aug 7, 2023	clinicaltrials